Q2 was yet another rough quarter for SAS, and while the outlook for the summer looks bright, it has so far made limited progress in its discussions with its various stakeholders regarding the burden-sharing in SAS Forward. Given the upcoming equity issue and debt conversion with likely significant shareholder dilution, we reiterate our SELL and SEK0.10 target price.
SAS’s elevated debt level and uncompetitive cost position remain challenging as there has been limited, if any, progress in its restructuring programme. We reiterate our SELL and have lowered our target price to SEK0.1 (0.4) on estimate cuts and the risk of significant dilution if the restructuring proves successful.
Although Q1 losses far exceeded our expectations, focus has been on the upcoming financial and operational restructuring, where SAS aims to convert debt to equity, raise new equity and cut costs by an extra SEK3.5bn p.a. We reiterate our SELL and SEK0.4 target price as we still find the stock overvalued, with significant dilution likely in April’s restructuring.
We consider this a negative report, with figures below expectations and a confirmation SAS is heading for a significant restructuring, of which SEK7.5bn in cost cuts is needed to make it investable, with more equity needed. We expect consensus PTP to fall by c20% and that a negative share price reaction is warranted.
With a Q1e PTP loss of SEKc1.9bn, elevated debt and an uncompetitive cost position, SAS seems as though it is edging closer to bankruptcy unless it can undergo restructuring. We reiterate our SELL, and have cut our target price to SEK0.4 (1) to reflect reduced estimates and increased financial risk.
Although the Q4 losses were lower than consensus forecast, SAS is still loss-making and it expects cash burn to increase going into the winter, while its balance sheet looks stretched against a subdued market outlook. We reiterate our SELL and SEK1 target price.
We consider this a slightly positive report for SAS, including lower than expected losses and positive cash flow. However, as the outlook remains subdued, the balance sheet is stretched and profitability absent we expect no significant 2022 consensus revisions.
We expect weak fiscal Q4 (August–October) results (due at 08:00 CET on 30 November), with passenger numbers c60% below Q4 2019 and rising Covid-19 cases globally yet again creating uncertainty. We still find the valuation rich, with its adj. EV c40–55% above historical levels. We reiterate our SELL and SEK1 target price.
SAS reported underlying Q3 figures more or less in line with our estimates and a better than expected cash burn. However, it now sees a slightly slower ramp-up of capacity going into the winter season, given still-high Covid-19 uncertainty and different possible recovery paths for leisure and business travel. This could affect Q4, which typically has a higher share of business travel. We reiterate our SELL and SEK1 target price.
We consider this a mixed report for SAS, including slightly lower than expected revenues, a better cash position and cash burn, and net profit in line with our expectation. We expect to make limited changes to our 2021e EPS on the back of the results and believe a neutral share price reaction is warranted.
We expect weak fiscal Q3 (May–July) results (due at 08:00 CET on 1 September), with passenger numbers 75% below Q3 2019 and rising Covid-19 cases globally creating uncertainty. We still find the valuation rich and adj. EV c45–60% above its historical average/median. We reiterate our SELL and SEK1 target price.
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
SAS reported weak Q2 results, as we expected, with revenues below our forecast and the negative Covid-19 impact still high. However, it sees positive signs ahead of the important summer season. That said, we reiterate our SELL and SEK1 target price as the stock is trading at a significant premium to its historical adj. EV (44–58% above the average/median), and we believe a recovery looks well discounted.
We consider this a weak report for SAS, including soft figures as expected, and with cash burn broadly in line with our expectation. On the positive side, the company was offered access to SEK3bn of additional liquidity by the Danish and Swedish governments yesterday, and its cash position was some SEK0.5bn above our expectation. We expect negative revisions to consensus EPS for 2021e on the back of the report.
We expect weak fiscal Q2 (February–April) results (due at 08:00 CET on 27 May), with passenger numbers down 73% YOY due to Covid-19. We still find the valuation rich, with the shares up close to 130% since the recapitalisation and the adj. EV c38–52% above the group’s historical average/median. We reiterate our SELL and SEK1 target price.
SAS reported a weak set of Q1 results, as expected, including higher revenues than we expected, offset by higher costs, and a very weak cash position, badly hit by negative working capital effects. The company continues to see limited demand in the foreseeable future, but remains confident in a more normalised 2022. We expect c7% negative revisions to consensus 2021e net profit on the back of the results and expect a negative share price reaction.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.